HK1039117B - 新的哌啶-4-磺酰胺化合物、其制备方法和含有它们的药物组合物 - Google Patents

新的哌啶-4-磺酰胺化合物、其制备方法和含有它们的药物组合物 Download PDF

Info

Publication number
HK1039117B
HK1039117B HK02100331.6A HK02100331A HK1039117B HK 1039117 B HK1039117 B HK 1039117B HK 02100331 A HK02100331 A HK 02100331A HK 1039117 B HK1039117 B HK 1039117B
Authority
HK
Hong Kong
Prior art keywords
compound
formula
product
ethyl
methyl
Prior art date
Application number
HK02100331.6A
Other languages
English (en)
Chinese (zh)
Other versions
HK1039117A1 (en
Inventor
J-L‧佩格里昂
J-L‧佩格裏昂
A‧迪辛格斯
C‧波特温
J-P‧维莱恩
N‧维兰尤夫
C‧波特溫
C‧索隆
M-P‧伯谷格诺
J-P‧維萊恩
N‧維蘭尤夫
M-P‧伯谷格諾
Original Assignee
瑟维尔实验室
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 瑟维尔实验室 filed Critical 瑟维尔实验室
Publication of HK1039117A1 publication Critical patent/HK1039117A1/xx
Publication of HK1039117B publication Critical patent/HK1039117B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
HK02100331.6A 2000-01-31 2002-01-16 新的哌啶-4-磺酰胺化合物、其制备方法和含有它们的药物组合物 HK1039117B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0001171 2000-01-31
FR0001171A FR2804429B1 (fr) 2000-01-31 2000-01-31 Nouveaux derives de 4-sulfonamides piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
HK1039117A1 HK1039117A1 (en) 2002-04-12
HK1039117B true HK1039117B (zh) 2007-09-07

Family

ID=8846469

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02100331.6A HK1039117B (zh) 2000-01-31 2002-01-16 新的哌啶-4-磺酰胺化合物、其制备方法和含有它们的药物组合物

Country Status (24)

Country Link
US (1) US6323217B2 (enExample)
EP (1) EP1122254B1 (enExample)
JP (1) JP3513493B2 (enExample)
KR (1) KR100463369B1 (enExample)
CN (1) CN1298705C (enExample)
AR (1) AR027335A1 (enExample)
AT (1) ATE294175T1 (enExample)
AU (1) AU774808B2 (enExample)
BR (1) BR0100234A (enExample)
CA (1) CA2332513C (enExample)
DE (1) DE60110278T2 (enExample)
DK (1) DK1122254T3 (enExample)
EA (1) EA003096B1 (enExample)
ES (1) ES2241757T3 (enExample)
FR (1) FR2804429B1 (enExample)
HK (1) HK1039117B (enExample)
HU (1) HUP0100489A3 (enExample)
MX (1) MXPA01000945A (enExample)
NO (1) NO320387B1 (enExample)
NZ (1) NZ509636A (enExample)
PL (1) PL345528A1 (enExample)
PT (1) PT1122254E (enExample)
SI (1) SI1122254T1 (enExample)
ZA (1) ZA200100864B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ521978A (en) * 2000-04-28 2004-10-29 Acadia Pharm Inc Compounds that affect cholinergic receptors and are particularly muscarinic agonists
EP1535912A1 (en) * 2000-04-28 2005-06-01 Arcadia Pharmaceuticals Inc. Muscarinic agonists
AR040336A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
AU2003284402A1 (en) * 2002-11-15 2004-06-15 Yamanouchi Pharmaceutical Co., Ltd. Antagonist to melanin-concentrating hormone receptor
JP2008507492A (ja) * 2004-07-23 2008-03-13 バイエル・クロツプサイエンス・エス・アー 殺菌剤としてのｎ−［２−（４−ピリジニル）エチル］ベンズアミド誘導体
ATE527258T1 (de) * 2004-07-28 2011-10-15 Takeda Pharmaceutical Pyrroloä2,3-cüpyridinverbindung, verfahren zu deren herstellung und anwendung
TW200630337A (en) * 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
ES2362617T3 (es) * 2005-02-25 2011-07-08 Kowa Company, Ltd. Proceso para la producción de haluro de 4-fluoroisoquinolin-5-sulfonilo o una de sus sales.
WO2007110449A1 (en) 2006-03-29 2007-10-04 Euro-Celtique S.A. Benzenesulfonamide compounds and their use
TW200812963A (en) 2006-04-13 2008-03-16 Euro Celtique Sa Benzenesulfonamide compounds and the use thereof
US8791264B2 (en) 2006-04-13 2014-07-29 Purdue Pharma L.P. Benzenesulfonamide compounds and their use as blockers of calcium channels
CL2007003223A1 (es) * 2006-11-10 2008-01-11 Wyeth Corp Compuestos derivados de piperidinil 4-arilsulfonamidas n-sustituidas, que actuan como moduladores de la proteina sfrp-1; proceso para preparar los compuestos; co mposicion farmaceutica que comprende a dichos copmpuestos y uso de los compuestos para preparar medicamentos para el tratamiento de enfermedades.
WO2008124118A1 (en) * 2007-04-09 2008-10-16 Purdue Pharma L.P. Benzenesulfonyl compounds and the use therof
US8765736B2 (en) 2007-09-28 2014-07-01 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
AR080375A1 (es) 2010-03-05 2012-04-04 Sanofi Aventis Procedimiento para la preparacion de 2-(cicloheximetil)-n-{2-[(2s)-1-metilpirrolidin-2-il] etil}-1,2,3,4-tetrahidroisoquinolina- 7-sulfonamida
PL395470A1 (pl) 2011-06-29 2013-01-07 Adamed Spólka Z Ograniczona Odpowiedzialnoscia Sulfonamidowe pochodne amin alicyklicznych do leczenia chorób osrodkowego ukladu nerwowego

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956382A (en) * 1987-02-07 1990-09-11 Pfizer Inc. Sulfonamide anti-arrhythmic agents
US4857301A (en) * 1987-09-25 1989-08-15 Schering Corporation Sulfonamide compounds, compositions and method of use
FR2679906B1 (fr) * 1991-07-31 1995-01-20 Adir Nouvelles (isoquinolein-5 yl) sulfonamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser
AU6971794A (en) * 1993-05-26 1994-12-20 Smithkline Beecham Laboratoires Pharmaceutiques Novel compounds
FR2716679B1 (fr) * 1994-02-25 1996-04-05 Adir Nouvelles sulfonamides substituées, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
HN1997000027A (es) * 1996-12-06 1997-06-05 Pfizer Prod Inc Derivados de 6-fenil piridil - 2 amina

Also Published As

Publication number Publication date
EA200100090A2 (ru) 2001-08-27
EP1122254B1 (fr) 2005-04-27
AU774808B2 (en) 2004-07-08
PL345528A1 (en) 2001-08-13
NO20010522D0 (no) 2001-01-30
KR20010078210A (ko) 2001-08-20
DE60110278T2 (de) 2006-02-16
JP2001233874A (ja) 2001-08-28
ZA200100864B (en) 2001-08-08
JP3513493B2 (ja) 2004-03-31
NZ509636A (en) 2001-09-28
DE60110278D1 (de) 2005-06-02
FR2804429B1 (fr) 2003-05-09
EP1122254A3 (fr) 2001-11-28
HU0100489D0 (en) 2001-04-28
US20010034352A1 (en) 2001-10-25
PT1122254E (pt) 2005-07-29
CN1298705C (zh) 2007-02-07
SI1122254T1 (enExample) 2005-08-31
AU1674701A (en) 2001-08-02
CA2332513A1 (fr) 2001-07-31
BR0100234A (pt) 2001-08-28
MXPA01000945A (es) 2002-06-04
EA003096B1 (ru) 2002-12-26
HK1039117A1 (en) 2002-04-12
US6323217B2 (en) 2001-11-27
NO320387B1 (no) 2005-11-28
ES2241757T3 (es) 2005-11-01
NO20010522L (no) 2001-08-01
HUP0100489A2 (hu) 2002-05-29
FR2804429A1 (fr) 2001-08-03
EA200100090A3 (ru) 2001-10-22
DK1122254T3 (da) 2005-08-29
KR100463369B1 (ko) 2004-12-23
AR027335A1 (es) 2003-03-26
CN1314345A (zh) 2001-09-26
HUP0100489A3 (en) 2002-10-28
ATE294175T1 (de) 2005-05-15
CA2332513C (fr) 2005-11-29
EP1122254A2 (fr) 2001-08-08

Similar Documents

Publication Publication Date Title
CN1304382C (zh) 用于治疗炎性、免疫或心血管疾病的新的p2x7受体拮抗剂
CN1298715C (zh) 作为组胺h3拮抗剂的非咪唑化合物
CN1142910C (zh) 酰胺化合物
CN1780621A (zh) 作为γ分泌酶抑制剂的磺酰胺衍生物
HK1039117A1 (en) New piperidine-4-sulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them
CN1628100A (zh) γ－分泌酶抑制剂
CN1331688A (zh) 氨基吡啶衍生物
CN1070404A (zh) 新的杂环衍生物
CN1197458A (zh) 具有磷酯酶a2抑制活性的吡咯烷衍生物
CN1615300A (zh) 苯并咪唑衍生物以及它们作为gnrh拮抗剂的用途
CN1128756A (zh) 作为人速激肽iii受体的选择性拮抗剂的化合物及其用途
CN1476434A (zh) 新化合物
CN1753670A (zh) 新苯并咪唑和咪唑并吡啶衍生物及其作为药物的用途
CN1491208A (zh) 酰化的6,7,8,9-四氢-5h-苯并环庚烯基胺和它们作为药物的用途
CN1152873C (zh) 新的二苯基哌啶衍生物
CN1642927A (zh) 环状酰胺
CN1163495C (zh) 吡啶化合物、其制备方法和含有它们的药物组合物
CN1582280A (zh) 作为cxc趋化因子受体拮抗剂的3,4－二－取代的哒嗪二酮
CN1152879C (zh) 萘啶衍生物
CN1092425A (zh) 吲哚衍生物、其制造方法及其医药用途
CN1571781A (zh) 4－咪唑啉－2－酮化合物
CN1993358A (zh) 作为趋化因子受体拮抗剂的噻唑衍生物
CN1065243C (zh) 新的二氮杂萘衍生物
CN1100425A (zh) 噻唑并嘧啶衍生物
CN1414961A (zh) 作为神经激肽拮抗剂的取代的肟和腙

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110123